Tafoxiparin, a novel drug candidate for cervical ripening and labor augmentation: a letter

Am J Obstet Gynecol. 2023 Dec;229(6):700-701. doi: 10.1016/j.ajog.2023.06.033. Epub 2023 Jun 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cervical Ripening
  • Female
  • Humans
  • Labor, Induced
  • Misoprostol*
  • Oxytocics*
  • Pregnancy

Substances

  • Oxytocics
  • Misoprostol